A Lost Opportunity: Underutilization of Systemic Therapy in T3N0M0 Non-small Cell Lung Cancer
{{output}}
Introduction: Treatment guidelines for non-small cell lung cancer (NSCLC) include systemic therapy for tumors >5 cm, even in the absence of metastatic/nodal disease. This study sought to evaluate the utilization rate of systemic ... ...
